Teva Pharmaceutical Industries Ltd (TEVA)
13.98
-0.10
(-0.75%)
USD |
NYSE |
May 03, 16:00
14.04
+0.06
(+0.47%)
After-Hours: 20:00
Teva Pharmaceutical Industries Total Liabilities (Quarterly): 35.35B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 35.35B |
| September 30, 2023 | 34.58B |
| June 30, 2023 | 35.39B |
| March 31, 2023 | 34.84B |
| December 31, 2022 | 35.41B |
| September 30, 2022 | 34.73B |
| June 30, 2022 | 36.10B |
| March 31, 2022 | 36.80B |
| December 31, 2021 | 36.42B |
| September 30, 2021 | 36.40B |
| June 30, 2021 | 37.88B |
| March 31, 2021 | 38.03B |
| December 31, 2020 | 39.58B |
| September 30, 2020 | 39.14B |
| June 30, 2020 | 40.17B |
| March 31, 2020 | 40.74B |
| December 31, 2019 | 42.41B |
| September 30, 2019 | 42.32B |
| June 30, 2019 | 44.17B |
| March 31, 2019 | 44.03B |
| December 31, 2018 | 44.89B |
| September 30, 2018 | 45.93B |
| June 30, 2018 | 47.66B |
| March 31, 2018 | 49.08B |
| December 31, 2017 | 51.87B |
| Date | Value |
|---|---|
| September 30, 2017 | 55.79B |
| June 30, 2017 | 56.75B |
| March 31, 2017 | 55.53B |
| December 31, 2016 | 58.06B |
| September 30, 2016 | 61.72B |
| June 30, 2016 | 25.90B |
| March 31, 2016 | 24.54B |
| December 31, 2015 | 24.31B |
| September 30, 2015 | 25.72B |
| June 30, 2015 | 27.29B |
| March 31, 2015 | 24.27B |
| December 31, 2014 | 23.06B |
| September 30, 2014 | 22.94B |
| June 30, 2014 | 23.14B |
| March 31, 2014 | 23.86B |
| December 31, 2013 | 24.87B |
| September 30, 2013 | 25.46B |
| June 30, 2013 | 25.89B |
| March 31, 2013 | 25.26B |
| December 31, 2012 | 27.74B |
| September 30, 2012 | 26.51B |
| June 30, 2012 | 25.99B |
| March 31, 2012 | 27.27B |
| December 31, 2011 | 27.80B |
| September 30, 2011 | 18.34B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
34.58B
Minimum
Sep 2023
44.17B
Maximum
Jun 2019
37.92B
Average
36.80B
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Viatris Inc | 27.22B |
| Alvotech | 1.883B |
| AstraZeneca PLC | 64.79B |
| Corcept Therapeutics Inc | 114.81M |
| GSK PLC | 57.17B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 43.48B |
| Shareholders Equity (Quarterly) | 7.506B |
| Debt to Equity Ratio | 2.642 |
| Current Ratio | 1.019 |
| Net Debt Paydown Yield | 2.45% |